West Hertfordshire Hospitals NHS Trust. Finance Report. Period 12. April to March 2009

Similar documents
Kingston Hospital NHS Foundation Trust. Finance Report December 2017 (Month 09)

Trust Board Meeting: Wednesday 13 November 2013 TB

Agenda Item 7 Date: 30 November Rob Forster, Director of Finance & IM&T. Approve Adopt Receive for information

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 4 July 2018

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07)

Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive. Author: Lynne Abbott, Head of Financial Management

Finance Report: 2014/15 Month 9. Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015

Month 10 Finance Report

Finance Report M4 2016/17

Clive Field, Interim Director of Finance and Performance. 20 June 2016

Trust Board Meeting 24th February 2011 FINANCE REPORT for the period ending 31st January 2011 (Month 10)

MANCHESTER UNIVERSITY NHS FOUNDATION TRUST BOARD OF DIRECTORS

Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010

Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000

Board of Directors Meeting Report 25 May Agenda item 49/16

345,780 Financed by: Taxpayers' Equity 360, , , ,617

Finance Assurance Report. March 2017

Forecast Position. Detailed financial statements are included in the Appendix attached to this report.

INDEPENDENT TRUST FINANCING FACILITY APPLICATION

MERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY

Corporate Performance Report 2015/16

Paper Finance Report. Month 11 (February 2016)

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 8 May 2018

Forecast Position. Detailed financial statements are included in the Appendix attached to this report. March 2018 $Ms Year to Date $Ms Full Year $Ms

1: Product Profitability Analysis - Exercise

Finance Assurance Report. February 2017

Paper Finance Report. Month 9 (December 2015)

Forecast Position. Detailed financial statements are included in the Appendix attached to this report.

Item 6. Monthly Finance Report For November Prepared by: Stephen Dunham Financial Controller

EXECUTIVE SUMMARY EXECUTIVE SUMMARY

Constructing a Cash Flow Forecast

healthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning.

Jason Dorsett, Chief Finance Officer

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

Corporate Performance Report 2013/14

BNSSG CCG Governing Body Meeting

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

Integrated Performance Report: Strategic Overview. Month /12

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan.

EXECUTIVE SUMMARY. REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR:

XML Publisher Balance Sheet Vision Operations (USA) Feb-02

2015/16 Financial Performance (Month 7) The Trust is planning for a deficit of 34.1m in 2015/16, including delivery of 43m of CIP.

HSCIC Financial Management and Reporting

Board/Committee Prompts Does the Board require any additional information reported in future papers?

2016/17 Financial Performance

SUMMARY OF OPERATING RESULTS DECEMBER UWHC Finance Committee & Authority Board

Board of Directors October 2018 and YTD Financial Report

Factor Leave Accruals. Accruing Vacation and Sick Leave

Integrated Financial Projections => replace by your own logo

Integrated Performance Report M Executive Summary

Exam 1 Problem Solving Questions Review

Spheria Australian Smaller Companies Fund

GOVERNING BODY MEETING held in public 30 September 2015 Agenda Item 2.1

Northern Gateway Toll Road. Operating report for the 12 months ending 30 June 2010

HIPIOWA - IOWA COMPREHENSIVE HEALTH ASSOCIATION Unaudited Balance Sheet As of July 31

HIPIOWA - IOWA COMPREHENSIVE HEALTH ASSOCIATION Unaudited Balance Sheet As of January 31

This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017.

% of Cardiac Arrests with Successful Return of Spontaneous Circulation

[Insert Subheading] Click to edit Master text styles. Shop Direct Limited. Q1 FY18 Results. Three months ended 30 September 2017.

WESTWOOD LUTHERAN CHURCH Summary Financial Statement YEAR TO DATE - February 28, Over(Under) Budget WECC Fund Actual Budget

Cash & Liquidity The chart below highlights CTA s cash position at December 2017 compared to December 2016.

Cash & Liquidity The chart below highlights CTA s cash position at September 2017 compared to September 2016.

THE B E A CH TO WN S O F P ALM B EA CH

Asset Manager Performance Comparison

Asset Manager Performance Comparison

TERMS OF REFERENCE FOR THE INVESTMENT COMMITTEE

The Royal Wolverhampton NHS Trust

Financial Results for the Six Months Ended 31 December 2016

Integrated Financial Projections

Cook County Health and Hospitals System. Financial Statements for the Month Ended June 30, 2010

Agenda Item: 4.4 Finance Report

QUESTION 2. QUESTION 3 Which one of the following is most indicative of a flexible short-term financial policy?

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Finance Report. Paul Goddard, Assistant Director of Finance

BANNER HEALTH Investor Conference Call

The total number of people officially waiting for treatment to begin is likely to be around 5.38 million compared to the current 4.08 million.

The year to date is less than budget and prior year by 15.4 million and 11.6 million, respectively.

Report. Chris Ford Joint Chief Finance Officer

Finance Report, end of November 2015 (month eight)

Agenda Item 7.3 CCG BOARD EXECUTIVE SUMMARY SHEET

Financial Report As of June 30, 2017

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST

DECEMBER KPI REPORT. Service Provider SLA Performance Core and Non-Core Settlement Systems Core and Non-Core BSC Systems. Supplier Performance

Agenda Item 9.1. Meeting / Committee. Meeting Date. 25 September Board of Directors. Information. This paper is for

Finance Performance Report

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

Using projections to manage your programs

TRUST BOARD PART I OCTOBER 2011 Agenda Item Number: 161/11 Enclosure Number: (3) Finance Report. Regular reporting. For information/awareness

For Assurance x For decision For discussion To note

Financial & Business Highlights For the Year Ended June 30, 2017

Buad 195 Chapter 4 Example Solutions, Pre-Midterm Page 1 of 9

Business & Financial Services December 2017

FINANCIAL MANAGEMENT STRATEGY REPORT ON OUTCOMES FOR THE YEAR ENDED MARCH 31, 2016

2017/18 Financial Performance

Fiscal Year 2018 Project 1 Annual Budget

Review of Membership Developments

Cash & Liquidity The chart below highlights CTA s cash position at March 2017 compared to March 2016.

Contact for further information: Keith Mattinson - Director of Corporate Services Telephone Number

FEBRUARY 2015 FINANCE REPORT FOR ET DISCUSSION FINANCIAL OVERVIEW & KEY RISK AREAS

Transcription:

West Hertfordshire Hospitals NHS Trust Finance Report Period 12 April to March 2009 Presented by Phil Bradley (Acting) Director of Finance 17 April 2009 1

Summary Financial Overview as at 31 March 2009 Income & Expenditure Balance Sheet 2008/09 Income & Expenditure Description Plan Actual Variance Income 238.9 241.7 2.8 Pay (146.9) (148.5) (1.6) Non Pay (87.6) (88.8) (1.2) Total Expenditure (234.5) (237.3) (2.8) Surplus/(Deficit) 4.4 4.4 (0.0) 5 4 3 2 1 0 Cumulative Surplus Income & Expenditure 2008/09 Actual Plan Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 40 35 30 25 20 15 10 5 0 Capital Expenditure Cumulative Cash Resource Limit for year 37.8m Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Monitor Financial Risk Ratings 2008/09 Underlying Performance 4 Achievement of Plan 4 Financial Efficiency 3 Liquidity 1 Overall Rating 2 Risks and Assumptions 14 12 10 8 6 4 2 0 Trust Savings 2008/09 Actual Target Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar 35 30 25 20 15 10 5 0 Year End 07/08 A nalysis of C ash, D eb t o rs & C red it o rs ( C red it ors sho wn as po sit ive) Jan Feb M ar 2008/09 Cash Stock Debtors Creditors Debtor Days: 13 Creditor Days: 33 Figures reported here are unaudited but based on a detailed review of the ledger. Variance By Division '000 () %Net Budget Summary Medicine (0.3) (0.7)% M12 M1-M12 Target Variance Surgery (5.2) (11.1)% Ave from Ave - The planned 4.4m surplus has been achieved. Women's (1.0) (4.3)% - 11.3m savings have been delivered. C linical Support 0.5 1.9% By Value 71% 70% 95% 28% - 9.6m savings have been delivered recurrently. Other 0.7 3.6% By Volume 66% 67% 95% 25% - 5.3m of capital cash is reflected in the Balance Sheet Facilities 1.1 11.2% Estates (0.3) (3.2)% C entral 4.1 2.0% C orporate 0.4 2.2% Total Variance (0.0) 2 Cumulative Better Payment Performance

Introduction At Month 12, the Trust has achieved its budgeted surplus of 4.4m. The table below summarises the Trust s performance against key indicators. Section Target Performance Key Issues Performance Rating 1 Deliver a surplus Income & Expenditure position 4.4m surplus Normalised surplus is 0.5m Green 3 Remain within the External Financing Limit (EFL) 24.3m The Trust has contained expenditure within its allocated External Financing Limit. Green 4 Remain within the Capital Resource Limit (CRL) 32.9m The Trust has contained capital expenditure within the CRL. Green 5 Savings Plan 11.3m 11.3m savings have been delivered against planned schemes. 11.3m Green 0.3m Red 6 Better Payment code - Cumulative target 95% Number: 67% Value: 70% Delays in invoice sign off in those departments not yet using electronic authorisation Plans in place to migrate over the coming months Red Table 1 In the April 2008 Finance Report, the Board was advised that the Financial Risk Rating (FRR) was based on Strategic Health Authority calculations. As the Trust is moving towards Foundation Trust status, the FRR below has been calculated according to Monitor s methodology, as set out in its Long Term Financial model. 3

Financial Risk Ratios Monitor Calculation Financial Risk Ratings 2008/09 Criteria Metric Weight 5 4 3 2 1 Score 08/09 Risk ratings 08/09 Underlying performance EBITDA margin % 25% 11 9 5 1 <1 10.2% 4 Achievement of plan EBITDA achieved % 10% 100 85 70 50 <50 92.3% 4 Financial efficiency Return on assets % 20% 6 5 3 2 <-2 5.1% 4 I&E surplus margin % 20% 3 2 1-2 <-2 1.8% 3 Liquidity Liquid ratio days 25% 35 25 15 10 <10 1.5 1 Average 3.1 Overriding rules Overriding rules At least one criteria on Plan 1 or 2 (1.1) Overall rating Table 2 Overall rating 2 For comparison, SHA FRR ratios are shown below: Financial Risk Ratios SHA Calculation Financial Risk Ratings Mar-09 Criteria Metric Weight 5 4 3 2 1 Score 08/09 Risk ratings 08/09 Underlying performance EBITDA margin % 25% 11 9 5 1 <1 10.2% 4 Achievement of plan EBITDA achieved % 10% 100 85 70 50 <50 100.4% 5 Financial efficiency Return on assets % 20% 6 5 3 2 <-2 5.5% 4 I&E surplus margin % 20% 3 2 1-2 <-2 1.8% 3 Liquidity Liquid ratio days 25% 35 25 15 10 <10 20.4 3 Average 3.65 Overriding rules Overriding rules At least one criteria on Plan 1 or 2 0 Overall rating Table 3 Overall rating 4 4

The schedule below summarises differences between the two sets of ratios: Ratio Difference in Calculation Effect of Difference EBITDA achieved Return on Assets (ROA) Liquidity Table 4 In Year 1 Monitor calculate EBITDA achieved April to February. SHA s formula runs April to March. SHA calculate return on equity; Monitor calculates return on equity plus loans. The SHA s formula includes stock and is based on the current year. Monitor exclude stock from calculations and base the rating on the prior year s balance sheet. Due to the working of the models, March s improvement in EBITDA compared to budgeted EBITDA of 1.9m is included in the SHA calculation but excluded from Monitor s. The Monitor ratio is therefore lower. 0.4% difference that is not material The SHA s calculation is higher as the inclusion of stock gives a higher liquidity figure. The SHA s calculation also includes the reduction in net current liabilities in 2008/09. The most significant difference is how liquidity is calculated. Using the Monitor calculations, liquidity rates 1. This then triggers an overriding rule that the maximum overall score allowable is 2. The Board is asked to note an apparent contradiction in the Monitor Long Term Financial Model (LTFM) which appears to give a maximum allowable score of 3. This is being clarified for the next iteration of the LTFM. 1 Deliver a surplus Income & Expenditure position Summary Results 1.1 Summary results for 2008/09 are shown below. Appendix 1 gives a more detailed statement of Income and Expenditure. Category 2008/09 2008/09 Variance Budget Actuals () () () Income SLA Income 208.8 211.9 3.1 Other NHS Income 23.8 23.6 (0.2) Other Non NHS Income 6.3 6.2 (0.1) Expenditure Pay (146.4) (148.5) (2.1) Non-pay (67.5) (68.6) (1.1) Reserves (1.0) 1.0 Unidentified savings 0.3 (0.3) EBITDA 24.3 24.6 0.3 Depreciation (10.5) (10.5) (0.0) Dividend Payable (8.8) (8.8) 0.0 Interest (0.6) (0.9) (0.3) Surplus 4.4 4.4 (0.0) Table 5 5

Income 1.2 SLA income is based on provisional activity to March 2009. At month 12, contract income shows over performance against plan of 3.1m. The 3.1m income variance is due in the main to additional income from elective and outpatient activity in order to achieve 18-week waiting list targets. The table below sets out Divisional income performance: Divisional Income 2008/09 Income Budget 2008/09 Actual Income Variance Over / (Under) Reason Medicine 9.7 9.7 0.0 Surgery 3.1 2.6 (0.5) Lower recharge income Women's & Children's 1.9 2.1 0.2 Clinical Support 4.0 3.9 (0.2) Lower private patient income Estates 0.4 0.4 0.1 Facilities 3.0 3.1 0.1 Contract Income 204.7 208.8 4.1 Income from achieving waiting list targets Corporate 12.0 11.0 (1.0) Reduction in training income Total 238.8 241.7 2.8 Table 6 Expenditure 1.3 2008/09 pay and non-pay costs are shown in the tables below. Pay and Non Pay 2008/09 14 12 10 8 6 4 Staffing Non Pay Pay Budget Non-Pay Budget 2 0 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Table 7 6

Bank & Agency Staffing Spend 2008/09 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Agency Bank Budget Table 8 Pay costs for the year are 1.6m over budget. Overspends on agency staff of 6.1m and bank staff of 5.5m are offset by under spends of 10m on permanent staff. In total, 11.2% of the Trust s 2008/09 staff costs represented overtime, agency or bank staff usage against an efficiency benchmark of 3%. Weekly meetings chaired by the Director of Workforce are being undertaken with the divisions to action reduced usage of temporary staff and to improve recruitment and retention of staff within the Trust. Appendix 1a provides an analysis by Division and staff group of cumulative staff costs and average paid whole time equivalents for 2008/09. Appendix 2 provides an analysis of non-pay. Divisional Position 1.4 The tables below analyse the Trust s year-end position by Division. The impact of unidentified savings has been shown against pay. Negative figures denote an overspend against expenditure or an under-recovery of income. 7

Financial Performance April 2008 to March 2009 by Division Division Pay Non-pay Income Grand Total % % % % Medicine (0.8) (1.9) 0.4 2.4 0.0 0.0 (0.3) (0.7) Surgery (2.5) (6.5) (2.2) (18.9) (0.5) (15.9) (5.2) (11.1) Women's (0.5) (2.3) (0.7) (22.5) 0.2 0.9 (1.0) (4.3) Clinical Support 0.7 3.2 (0.1) (1.4) (0.2) (3.9) 0.5 1.9 Facilities 0.2 36.5 0.8 6.3 0.1 0.5 1.1 11.2 Estates (0.0) 0.0 (0.3) (4.9) 0.1 18.8 (0.3) (3.2) Corporate / Central 0.4 2.1 1.6 5.3 3.2 1.5 5.2 3.1 Total (2.4) (0.4) 2.8 0.0 Table 9 2008-09 Budget Variance by Division 5.5 4.5 3.5 2.5 1.5 0.5 (0.5 ) (1.5 ) Medicine Surgery Women's Clinical Support Facilities Estates Corporate / Central (2.5 ) (3.5 ) (4.5 ) (5.5 ) Table 10 Recurrent Financial Position 1.5 Appendix 1b shows the Trust s baseline run-rate, or underlying financial position, adjusted for non-recurrent income and expenditure. 2 Remain Within External Financing Limit (EFL) 2.1 This is a cash amount receivable based on the Trust s capital requirements. The Trust has met its financial duty to contain spend within this limit. 8

3 Remain Within Capital Resource Limit (CRL) 3.1 The Trust has met its financial duty to contain capital commitments within this limit. 4 Intelligent Savings Plan 4.1 The Trust has achieved 11.3m of its planned 11.6m 2008/09 Cost Improvements. Division Savings Target () Savings Delivered () Variance () Surgery 3.8 3.6 (0.2) Medicine 3.6 3.0 (0.6) Clinical Support 0.7 0.8 0.1 Corporate 1.7 1.7 0.0 Estates / Facilities 0.8 0.9 0.1 Women s 1.0 1.3 0.3 Total 11.6 11.3 (0.3) Table 11 4.2 The following table sets out the delivery of 2008/09 savings: Division Target 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 1.9 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 Planned Gateway 3 Forecast Gateway 3 Non- Recurrent Savings Surgery 3.6 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 3.63 3.63 0.57 Medicine 3.8 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 3.00 3.00 0.35 Clin Supp 0.7 2 2 1 1 1 1 1 0.77 0.77 0.25 Corporate 1.7 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1.70 1.70 0.53 Estates & Facilities 0.74 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.84 0.81 - Clinical Engineering 0.06 0.06 0.06 - Women & Children's 1.0 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1.30 1.32 - Total Target 11.6 11.29 11.28 1.70 KEY = RECURRENT SAVINGS = TARGET = NON RECURRENT SAVINGS Table 12Ta4.444.ble 19 9

5 Better Payment Practice Code (BPPC) (B 5.1 The cumulative target of paying 95% of invoices received within 30 days has not been achieved. 2008/09 cumulative figures are 67% by number and 70% by value. 5.2 The charts that follow set out performance against planned trajectories to achieve a 95% target. Payment of Non-NHS Creditors within 30 days 2008/09 100% 90% 80% 70% 60% Non-NHS Trajectory Target No. Non-NHS Achieved Value Non-NHS Achieved 50% 40% 30% Table 13 Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Payment of NHS Creditors within 30 days 2008/09 100% 90% 80% 70% 60% 50% Target NHS Trajectory No. NHS Achieved Value NHS Achieved 40% 30% Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Table 14 5.3 Payment times have improved compared to 2007/08. However, the Trust is still not meeting the required payment times target. Existing delays within the Trust will be resolved through the planned roll-out of electronic authorisation of invoices, scheduled to be completed by the end of Quarter 2 2009/10. Creditor days have reduced from 37 at Month 11 to 33 at the end of Month 12. 10

5.4 The Strategic Health Authority s Director of Finance has advised all East of England Finance Directors to include a monthly update to their Boards on the payment record relating to the Small and Medium Enterprises 10-days payment initiative. Measurement of performance against this target will require extensive modification to the Purchase Ledger and will require time to allow for training. The Trust s current priority therefore remains to continue with ongoing schemes to improve payment times. These include invoice scanning and streamlining ordering processes as well as the electronic authorisation of invoices. Where it is identified that the invoice relates to a small / medium business, authorised invoices are paid within 10 days. 6 Cash Management 6.1 At 31 March, the Trust had a cash balance of 5.3m: Capital unspent 5.3 Prepayments (1.3) Revenue receipts in advance 2.1 VAT recoverable from HMRC (0.8) Total Cash Balance 5.3 Table 15 6.2 A statement summarising the cash effect of 2008/09 operating activities is set out below: The year end cash balance of 5.3m relates to unspent capital. 6.3 At 31/03/2009, the Trust s Creditor days are 33 and the Trust s Debtor days are 13. The improvement in Creditor days represents work to improve the speed of invoice payments. The increase in Debtor days is due to the year-end effect of not raising SLA invoices in advance. 11

Cash Flow Reporting 2008/09 West Herts Hospitals NHS Trust Plan Actual 31/03/2009 31/03/2009 EBITDA Excluding non cash operational items 24,518 24,194 Movement in Working Capital Stocks & work in progress 0 92 NHS trade debtors 865-1,027 Non NHS trade debtors -1,652 Accrued income 380 Prepayments 295 NHS Creditors -2,469 Trade creditors -348 2,047 Other creditors 4,935 Accruals -2,369 Deferred income 27 Provisions & liabilities -777-930 CF from operations 24,258 23,523 Capital expenditure Maintenance -331 Non maintenance -37,422-32,771 Cash receipt from asset sales 0 211 CF before financing -13,164-9,368 Movement in LT debtors 0-210 Interest Loans Other Interest paid on loans & leases -1,380-1,287 Interest received on cash balance 694 684 Drawdown of Loans and leases 27,000 27,000 Repayment of loans & leases -4,301-4,301 Public Dividend Capital received 0 1,616 Dividends paid -8,849-8,849 Net cash outflow / inflow from financing 13,164 14,653 Opening cash balance 0 0 Net cash outflow / inflow 0 5,285 Closing cash balance 0 5,285 12

7 Balance Sheet 7.1 The opening and unaudited closing balance sheets for the 2008/09 financial year are set out below: West Herts Hospitals NHS Trust 2008/09 2008/09 Opening Bal Actual as at as at 01/04/2008 31/03/2009 Fixed assets Land 96,671 100,795 Buildings 114,751 146,437 Dwellings 10,326 10,413 Fixtures 3,025 3,368 Plant & Equipment 6,909 11,556 I.M. & T. 2,022 1,500 A.I.C.O.C. 19,344 12,174 A.I.C.O.C. from donations 0 17 Intangible Fixed Assets 3,311 3,044 A.I.C.O.C Intangible 763 1,048 Total fixed assets 257,122 290,352 Current assets Stocks and work in progress 2,987 2,895 NHS trade debtors 8,936 9,963 Non NHS trade debtors 1,879 2,111 Accrued income 298 678 Prepayments 467 762 Cash at bank and in hand 169 5,382 Total current assets 14,736 21,791 Current liabilities (amounts due in less than one year) Bank overdraft 169 97 NHS Creditors 9,711 7,321 Trade creditors 2,830 2,990 Other creditors 443 5,378 Capital creditors 3,272 5,159 Interest payable creditor 21 0 Accruals 7,872 5,503 Deferred income 149 176 Total current liabilities 24,467 26,624 Net current assets (liabilities) (9,731) (4,833) Long term debtors 1,408 1,618 Total assets less current liabilities 248,799 287,137 Provisions for liabilities and charges 7,185 6,255 Total assets employed 241,614 280,882 Financed by Balance Sheet Reporting 2008/09 Loans Total Loans 8,960 31,659 Total Loans 8,960 31,659 Taxpayers equity Public dividend capital 169,984 171,600 Income and expenditure reserve (44,306) (47,974) Revaluation reserve 105,013 123,840 Donated asset reserve 1,963 1,757 Total funds employed 241,614 280,882 13

8 Capital Spending 8.1 Capital spend to the end of March totalled 33.1m, of which 23.4m related to the Acute Admissions Unit. A summary of capital expenditure is set out below: Table 16 West Hertfordshire Hospitals NHS Trust 2008/09 Capital Expenditure 1 April 2008 to 31 March 2009 2008/09 Budget 2008/09 Commitments Variance '000 '000 '000 07/08 b/fwd Commitments PACS 50 18 32 Other IT 28 123 (95) HAI (Infection Control) 139 150 (11) Other Backlog Maintenance 1,445 1,457 (12) Cath Lab 1,330 0 1,330 Total 07/08 b/f Commitments 2,992 1,748 1,244 08/09 Allocations Estates & Facilities 3,111 608 2,503 Equipment Replacement 1,879 2,270 (391) Service Developments 3,696 3,007 689 Information Technology 461 847 (386) MRI 1,035 0 1,035 Other 207 1,009 (802) Approved Operational Capital 13,381 9,489 3,892 DAHF 24,371 23,395 976 Total Capital Expenditure 37,752 32,884 4,868 2008/09 Funding 000s Depreciation 10,374 Interest Bearing Debt 27,000 Planned I&E surplus 4,400 Decontamination allocation 1,288 Loan Repayments (4,301) Offset to anticipated 2007/08 overspend (1,337) Funding for transfer of PPAS build to Trust 328 Total Capital Resource Limit 37,752 8.2 Total capital cash is calculated as follows: Capital expenditure underspend Plus capital spend accrued but not paid Total capital cash carried forward 4.9m 0.4m 5.3m 14

9 Conclusion 9.1 At 31 March, the Trust has achieved: its planned surplus of 4.4m and therefore remains on track to deliver cumulative statutory break-even in 2009/10 remained within its 2008/09 EFL remained within its 2008/09 CRL. 9.2 The Trust Board is asked to note this report and raise any comments for discussion. In particular, the Board is asked to note that the year-end surplus has been achieved through a number of non-recurrent events, including one-off income receipts, and Balance Sheet management. Presented by: Phil Bradley (Acting) Director of Finance 17 April 2009 15